Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT

Joohee Lee, Miles M. Sato, Marc N. Coel, Kyung-Han Lee and Sandi A. Kwee
Journal of Nuclear Medicine July 2016, 57 (7) 1058-1064; DOI: https://doi.org/10.2967/jnumed.115.169177
Joohee Lee
1Oncology Research Program, Queen’s Medical Center, Honolulu, Hawaii
2Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miles M. Sato
1Oncology Research Program, Queen’s Medical Center, Honolulu, Hawaii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc N. Coel
3Hamamatsu/Queen’s PET Imaging Center, Queen’s Medical Center, Honolulu, Hawaii; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung-Han Lee
2Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandi A. Kwee
3Hamamatsu/Queen’s PET Imaging Center, Queen’s Medical Center, Honolulu, Hawaii; and
4Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. 7 1058-1064
DOI 
https://doi.org/10.2967/jnumed.115.169177
PubMed 
26912444

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 24, 2015
  • Accepted for publication January 26, 2016
  • Published online July 1, 2016.

Article Versions

  • previous version (February 16, 2016 - 07:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Joohee Lee1,2,
  2. Miles M. Sato1,
  3. Marc N. Coel3,
  4. Kyung-Han Lee2 and
  5. Sandi A. Kwee3,4
  1. 1Oncology Research Program, Queen’s Medical Center, Honolulu, Hawaii
  2. 2Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  3. 3Hamamatsu/Queen’s PET Imaging Center, Queen’s Medical Center, Honolulu, Hawaii; and
  4. 4Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii
  1. For correspondence or reprints contact: Sandi A. Kwee, PET Imaging, Queen’s Medical Center, 1301 Punchbowl St., First Floor, Honolulu, Hawaii 96813. E-mail: kwee{at}hawaii.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 16 Citations
  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Therapy assessment of bone metastatic disease in the era of 223radium
    Elba Etchebehere, Ana Emilia Brito, Alireza Rezaee, Werner Langsteger, Mohsen Beheshti
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 S1
  • Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook
    Amy L. Vāvere, Peter J.H. Scott
    Seminars in Nuclear Medicine 2017 47 5
  • Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study
    Peijin Han, Aurelian Bidulescu, John R. Barber, Steven H. Zeisel, Corinne E. Joshu, Anna E. Prizment, Mara Z. Vitolins, Elizabeth A. Platz
    Cancer Causes & Control 2019 30 4
  • Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride
    Sandi A. Kwee, John Lim, Marc N. Coel
    Clinical Nuclear Medicine 2017 42 11
  • Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases
    Lavinia Vija Racaru, Mathieu Sinigaglia, Salim Kanoun, Fayçal Ben Bouallègue, Ilan Tal, Sévérine Brillouet, Mathilde Bauriaud-Mallet, Slimane Zerdoud, Lawrence Dierickx, Delphine Vallot, Olivier Caselles, Erwan Gabiache, Pierre Pascal, Frederic Courbon
    Nuclear Medicine Communications 2018 39 7
  • 18F-NaF/223RaCl2 theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcome
    Hossein Jadvar, Patrick M Colletti
    The British Journal of Radiology 2018 91 1091
  • Molecular Imaging of Recurrent and Metastatic Prostate Cancer
    Robert E. Ware, Scott Williams, Rodney J. Hicks
    Seminars in Nuclear Medicine 2019 49 4
  • Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer
    Luca Filippi, Viviana Frantellizzi, Agostino Chiaravalloti, Mariano Pontico, Maria Silvia De Feo, Ferdinando Corica, Melissa Montebello, Orazio Schillaci, Giuseppe De Vincentis, Oreste Bagni
    International Journal of Molecular Sciences 2021 22 6
  • Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician’s guide
    Sympascho Young, Wei Liu, Katherine Zukotynski, Glenn Bauman
    Expert Review of Anticancer Therapy 2021 21 6
  • Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
    Matteo Donadon, Egesta Lopci, Jacopo Galvanin, Simone Giudici, Daniele Del Fabbro, Ezio Lanza, Vittorio Pedicini, Arturo Chiti, Guido Torzilli
    Cancers 2021 13 3

Article usage

Article usage: February 2016 to April 2025

AbstractFullPdf
Feb 2016326041
Mar 2016224036
Apr 2016104019
May 2016131017
Jun 2016111016
Jul 20168251059
Aug 20162011434
Sep 2016136718
Oct 201687415
Nov 20166137
Dec 201665614
Jan 2017782228
Feb 2017361516
Mar 2017461617
Apr 20175066
May 2017472121
Jun 2017211610
Jul 2017121523
Aug 2017302010
Sep 201791111
Oct 2017242812
Nov 2017222314
Dec 201715143
Jan 201816168
Feb 201822165
Mar 201892011
Apr 201821244
May 201824249
Jun 201817174
Jul 201812114
Aug 20181282
Sep 2018161713
Oct 2018153016
Nov 2018121721
Dec 201871110
Jan 2019221615
Feb 2019202013
Mar 201992313
Apr 2019122712
May 201910913
Jun 201981611
Jul 2019131213
Aug 2019765
Sep 201912912
Oct 201912129
Nov 201910710
Dec 20191268
Jan 20206156
Feb 202011614
Mar 202091410
Apr 202071310
May 2020101717
Jun 2020787
Jul 20207102
Aug 20201351
Sep 202051225
Oct 2020151214
Nov 2020455
Dec 20201197
Jan 202121825
Feb 202121612
Mar 202144710
Apr 202142512
May 20214234
Jun 20219239
Jul 202151314
Aug 20211169
Sep 202142113
Oct 202161317
Nov 202121527
Dec 20214228
Jan 20221114
Feb 20226169
Mar 202201610
Apr 202211410
May 202241812
Jun 202241412
Jul 20221114
Aug 20221116
Sep 202221816
Oct 2022294
Nov 20220126
Dec 2022262
Jan 202331911
Feb 2023062
Mar 20232188
Apr 20232236
May 2023199
Jun 2023332
Jul 20231710
Aug 20233310
Sep 2023443
Oct 2023234
Nov 2023392
Dec 20231151
Jan 20247145
Feb 20243135
Mar 202421234
Apr 202454227
May 20246275
Jun 20242256
Jul 20243137
Aug 202461820
Sep 202441011
Oct 20244157
Nov 20242109
Dec 20241134
Jan 20253119
Feb 20252597
Mar 202512916
Apr 202533112
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (7)
Journal of Nuclear Medicine
Vol. 57, Issue 7
July 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT
Joohee Lee, Miles M. Sato, Marc N. Coel, Kyung-Han Lee, Sandi A. Kwee
Journal of Nuclear Medicine Jul 2016, 57 (7) 1058-1064; DOI: 10.2967/jnumed.115.169177

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT
Joohee Lee, Miles M. Sato, Marc N. Coel, Kyung-Han Lee, Sandi A. Kwee
Journal of Nuclear Medicine Jul 2016, 57 (7) 1058-1064; DOI: 10.2967/jnumed.115.169177
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • fluorocholine
  • PET/CT
  • castrate resistant prostate cancer
  • treatment response
  • tumor volume
SNMMI

© 2025 SNMMI

Powered by HighWire